evaluated the validity of genes for SQTS and revealed that the KCNH2 gene was classified as definitive, KCNQ1, KCNJ2 and SLC4A3 were classified as strong to moderate evidence. This evidence concerns the gene KCNH2 and Familial short QT syndrome.